Second trimester abortion by extra-amniotic PGF2 alpha infusion: experience of 178 cases.
Peat B.
Aust N Z J Obstet Gynaecol. 1991 Feb;31(1):47-51.
PMID:1872774
Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol.
Dickinson JE, Doherty DA.
Contraception. 2023 Sep;125:110080. doi: 10.1016/j.contraception.2023.110080. Epub 2023 May 26.
PMID:37245784
Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
Gemzell-Danielsson K, Lalitkumar S.
Reprod Health Matters. 2008 May;16(31 Suppl):162-72. doi: 10.1016/S0968-8080(08)31371-8.
PMID:18772097
Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
Lauersen NH, Secher NJ, Wilson KH.
Am J Obstet Gynecol. 1975 Aug 15;122(8):947-54. doi: 10.1016/0002-9378(75)90353-1.
PMID:1155530
Acceptability and clinical outcomes of first- and second-trimester surgical abortion by suction aspiration in Colombia.
DePiñeres T, Baum S, Grossman D.
Contraception. 2014 Sep;90(3):242-8. doi: 10.1016/j.contraception.2014.05.002. Epub 2014 May 14.
PMID:24939803
Complications of second trimester induction for abortion or fetal demise for patients with and without prior cesarean delivery.
Latta K, Barker E, Kendall P, Testani E, Laursen L, McClosky L, York S.
Contraception. 2023 Jan;117:55-60. doi: 10.1016/j.contraception.2022.06.011. Epub 2022 Jun 24.
PMID:35760083
Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol): a systematic review of Chinese trials.